Oncology: What You May Have Missed in 2023.

Autor: Coschi CH; Division of Medical Oncology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (C.H.C., L.D.)., Dodbiba L; Division of Medical Oncology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada (C.H.C., L.D.)., Guerry D; Associate Editor, Annals of Internal Medicine, and Emeritus Professor of Medicine, Perelman School of Medicine, Philadelphia, Pennsylvania (D.G.).

Publikováno v: Annals of internal medicine [Ann Intern Med] 2024 May; Vol. 177 (5_Supplement), pp. S57-S70. Date of Electronic Publication: 2024 Apr 16.

Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).

Autor: Piccirillo MC; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy., Chu Q; Cross Cancer Institute, Edmonton, Alberta, Canada., Bradbury P; University Health Network, Toronto, Ontario, Canada., Tu W; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Coschi CH; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Grosso F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy., Florescu M; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Mencoboni M; Oncology Unit ASL 3, Villa Scassi Hospital, Genova, Italy., Goffin JR; Juravinski Cancer Centre, Ontario, Canada., Pagano M; Medical Oncology, Comprehensive Cancer Centre, AUSL Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) of Reggio Emilia, Reggio Emilia, Italy., Ciardiello F; Oncology and Hematology Unit, University of Campania 'Luigi Vanvitelli,' Naples, Italy., Cecere FL; Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituti Fisioterapici Ospitalieri (IFO) Istituto Regina Elena, Rome, Italy., Vincent M; London Regional Cancer Program, London, Ontario, Canada., Ferrara R; Thoracic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milano, Italy., Dawe DE; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Canada., Hao D; Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, Alberta, Canada., Lee CW; British Columbia Cancer Agency, Surrey, British Columbia, Canada., Morabito A; Thoracic Oncology Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy., Gridelli C; Oncology Unit, S. Giuseppe Moscati Hospital, Avellino, Italy., Cavanna L; Oncology and Hematology Department, USL Piacenza, Guglielmo da Saliceto Hospital, Piacenza, Italy., Iqbal M; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada., Blais N; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada., Leighl NB; University Health Network, Toronto, Ontario, Canada., Wheatley-Price P; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada., Tsao MS; University Health Network, Toronto, Ontario, Canada., Ugo F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy., El-Osta H; Merck & Co, Inc., Rahway, New Jersey., Gargiulo P; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy., Gaudreau PO; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Tu D; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Sederias J; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Brown-Walker P; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Perrone F; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy., Seymour L; Canadian Cancer Trials Group, Kingston, Ontario, Canada. Electronic address: lseymour@ctg.queensu.ca., Laurie SA; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2023 Jun; Vol. 18 (6), pp. 813-819. Date of Electronic Publication: 2023 Feb 24.

Understanding the Attitudes and Beliefs of Oncologists Regarding the Transitioning and Sharing of Survivorship Care.

Autor: Coschi CH; Department of Medicine, McMaster University, 1200 Main Street West, Hamilton, ON L8N 3Z5, Canada., Bainbridge D; Juravinski Hospital and Cancer Centre, Department of Oncology, McMaster University, 711 Concession Street, Hamilton, ON L8V 1C3, Canada., Sussman J; Juravinski Hospital and Cancer Centre, Department of Oncology, McMaster University, 711 Concession Street, Hamilton, ON L8V 1C3, Canada.; Hamilton Health Sciences Juravinski Cancer Centre, 699 Concession Street, Hamilton, ON L8V 5C2, Canada.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Dec 19; Vol. 28 (6), pp. 5452-5465. Date of Electronic Publication: 2021 Dec 19.

Disruption of CDK-resistant chromatin association by pRB causes DNA damage, mitotic errors, and reduces Condensin II recruitment.

Autor: Ishak CA; a London Regional Cancer Program , London , Ontario , Canada.; b Department of Biochemistry , Western University , London , Ontario , Canada., Coschi CH; a London Regional Cancer Program , London , Ontario , Canada.; b Department of Biochemistry , Western University , London , Ontario , Canada., Roes MV; a London Regional Cancer Program , London , Ontario , Canada.; b Department of Biochemistry , Western University , London , Ontario , Canada., Dick FA; a London Regional Cancer Program , London , Ontario , Canada.; b Department of Biochemistry , Western University , London , Ontario , Canada.; c Children's Health Research Institute , London , Ontario , Canada.

Publikováno v: Cell cycle (Georgetown, Tex.) [Cell Cycle] 2017 Aug 03; Vol. 16 (15), pp. 1430-1439. Date of Electronic Publication: 2017 Jul 19.

Haploinsufficiency of an RB-E2F1-Condensin II complex leads to aberrant replication and aneuploidy.

Autor: Coschi CH; Authors' Affiliations:London Regional Cancer Program; Department of Biochemistry, and., Ishak CA; Authors' Affiliations:London Regional Cancer Program; Department of Biochemistry, and., Gallo D; Biochemistry, Donnelly Centre, University of Toronto; and., Marshall A; Authors' Affiliations:London Regional Cancer Program; Department of Biochemistry, and., Talluri S; Authors' Affiliations:London Regional Cancer Program; Department of Biochemistry, and., Wang J; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Cecchini MJ; Authors' Affiliations:London Regional Cancer Program; Department of Biochemistry, and., Martens AL; Authors' Affiliations:London Regional Cancer Program; Department of Biochemistry, and., Percy V; Authors' Affiliations:London Regional Cancer Program;, Welch I; Veterinary Services, Western University, London; Departments of., Boutros PC; Medical Biophysics, and Pharmacology and Toxicology, Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Brown GW; Biochemistry, Donnelly Centre, University of Toronto; and., Dick FA; Authors' Affiliations:London Regional Cancer Program; Children's Health Research Institute; Department of Biochemistry, and fdick@uwo.ca.

Publikováno v: Cancer discovery [Cancer Discov] 2014 Jul; Vol. 4 (7), pp. 840-53. Date of Electronic Publication: 2014 Apr 16.